Revolution Medicines
RVMD
161.20
+1.77
+1.11%
Revolution Medicines
US · RVMD
#499 by market cap
Listed 2020
161.20
+1.77
+1.11%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
About Revolution Medicines
Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.
- Founded
- 2004
- CEO
- Dr. Mark A. Goldsmith, M.D., PhD
- Employees
- 883
- Headquarters
- Redwood City, California, United States of America
- Fiscal year end
- 12-31
- Website
- revmed.com
Company profile
- Exchange
- US
- Symbol
- RVMD
- Market-cap rank
- #499
- Listing date
- 2020-02-13
- Market cap
- 34.87B
- Float cap
- 31.94B
- Shares out
- 216.29M
- Float shares
- 198.15M
Sectors & themes
Biotechnology
Fractional Shares JP
Quote time 2026-11-20 20:02:24 · For reference only, not investment advice and not tailored to your situation.
Revolution Medicines discussion 0 comments